Streetbeat News

Revenues

SBUX

Starbucks (NASDAQ:SBUX) has significantly outperformed the market over the past 15 years, with an average annual return of 15.92%. A $1000 investment in Starbucks 15 years ago would be worth $9,134.17 today. This highlights the power of compounded returns over time.

Portfolio Pulse from Benzinga Insights

October 10, 2024 | 2:30 pm

UNH

UnitedHealth Group (NYSE:UNH) has outperformed the market over the past 5 years, with an average annual return of 20.14%. A $1000 investment in UNH 5 years ago would now be worth $2,708.37. The article highlights the impact of compounded returns on investment growth.

Portfolio Pulse from Benzinga Insights

October 10, 2024 | 2:30 pm

DTSS

Datasea shares are experiencing an uptick following the company's pre-announcement of a year-over-year increase in Q1 revenue.

Portfolio Pulse from Benzinga Newsdesk

October 10, 2024 | 2:22 pm

NXGL

NEXTGEL shares rise as the company anticipates a year-over-year increase in Q3 preliminary revenue.

Portfolio Pulse from Benzinga Newsdesk

October 10, 2024 | 2:14 pm

ZJK

ZJK Industrial Co. Ltd. (NASDAQ:ZJK) experienced a 36% rise in its share price following its IPO, despite a subsequent selloff. The company plans to use IPO proceeds to expand its foundry operations, potentially in Vietnam, and diversify its market presence. ZJK's strong client list and respectable financials, despite its small scale, contribute to its market appeal.

Portfolio Pulse from The Bamboo Works

October 10, 2024 | 2:07 pm

CRUS

Analysts have provided mixed reviews for Cirrus Logic (NASDAQ:CRUS) over the past three months, with a range of ratings from bullish to indifferent. The average 12-month price target has increased by 20.47% to $153.0. Analysts have adjusted their ratings and price targets based on market conditions and company performance. Cirrus Logic has shown strong financial metrics, including a 17.98% revenue growth rate and a net margin of 11.25%.

Portfolio Pulse from Benzinga Insights

October 10, 2024 | 2:01 pm

AGIO

Analysts have mixed ratings for Agios Pharmaceuticals (NASDAQ:AGIO), with recent evaluations showing a decline in average price targets. The company's financial health shows challenges in profitability and returns, despite notable revenue growth.

Portfolio Pulse from Benzinga Insights

October 10, 2024 | 2:01 pm

FI

Fiserv (NYSE:FI) has significantly outperformed the market over the past 15 years, achieving an average annual return of 20.07%. A $1000 investment in Fiserv 15 years ago would be worth $15,293.83 today, highlighting the power of compounded returns.

Portfolio Pulse from Benzinga Insights

October 10, 2024 | 2:00 pm

NSC

Norfolk Southern (NYSE:NSC) has outperformed the market over the past 20 years with an average annual return of 13.15%, resulting in a $1000 investment growing to $11,542.49. The article highlights the power of compounded returns over time.

Portfolio Pulse from Benzinga Insights

October 10, 2024 | 2:00 pm

UMBF

Analysts have shown a positive shift in sentiment towards UMB Financial (NASDAQ:UMBF), with recent upgrades in ratings and price targets. The average 12-month price target has increased by 20.21% to $117.0. UMB Financial has demonstrated strong financial performance with a 5.99% revenue growth rate and a net margin of 29.08%.

Portfolio Pulse from Benzinga Insights

October 10, 2024 | 2:00 pm